ELOXX PHARMACEUTICALS, INC. Financing Cash Flow
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Financing Cash Flow of $67.42 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $60.39M, a 3120.59% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $7.03M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $1.88M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was -$865.00K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $8.81M, a 82.65% decline from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2021 was $50.79M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2020 was -$3.44M, a 107.35% decline from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2019 was $46.80M, a 16.70% decline from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 159 month | Net Cash Provided by (Used in) Financing Activities 162 month | Net Cash Provided by (Used in) Financing Activities 165 month | Net Cash Provided by (Used in) Financing Activities 168 month | Net Cash Provided by (Used in) Financing Activities 171 month | Net Cash Provided by (Used in) Financing Activities 174 month | Net Cash Provided by (Used in) Financing Activities 177 month | Net Cash Provided by (Used in) Financing Activities 180 month | Net Cash Provided by (Used in) Financing Activities 183 month | Net Cash Provided by (Used in) Financing Activities 186 month | Net Cash Provided by (Used in) Financing Activities 189 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $60.39M derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | $67.42M S-1 · filed 2026-09-11 | ||||||||||||||
| 2026-03-31 | $7.03M S-1/A · filed 2026-06-04 | |||||||||||||||
| 2025-12-31 | $11.00M S-1 · filed 2026-09-11 | |||||||||||||||
| 2025-06-30 | $1.88M derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | $1.01M S-1 · filed 2026-09-11 | ||||||||||||||
| 2025-03-31 | -$865.00K S-1/A · filed 2026-06-04 | |||||||||||||||
| 2024-12-31 | $3.44M S-1 · filed 2026-09-11 | |||||||||||||||
| 2023-12-31 | -$1.68M derived: S-1 12 month − 10-Q 9 month · filed 2026-09-11 | $1.99M derived: sum of 2 quarters · filed 2026-09-11 | $3.42M derived: sum of 3 quarters · filed 2026-09-11 | -$4.08M S-1 · filed 2026-09-11 | ||||||||||||
| 2023-09-30 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.10M derived: sum of 2 quarters · filed 2023-11-13 | -$2.40M 10-Q · filed 2023-11-13 | -$2.09M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2023-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$6.07M 10-Q · filed 2023-08-11 | -$5.76M derived: sum of 3 quarters · filed 2023-08-11 | -$4.26M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2023-03-31 | -$7.50M 10-Q · filed 2023-05-12 | -$7.19M derived: sum of 2 quarters · filed 2023-05-12 | -$5.69M derived: sum of 3 quarters · filed 2023-11-13 | -$5.69M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-12-31 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.81M derived: sum of 2 quarters · filed 2023-11-13 | $1.81M derived: sum of 3 quarters · filed 2023-11-13 | $8.81M 10-K · filed 2023-03-31 | ||||||||||||
| 2022-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.50M derived: sum of 2 quarters · filed 2023-11-13 | $8.50M 10-Q · filed 2023-11-13 | $8.34M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $7.00M 10-Q · filed 2023-08-11 | $6.84M derived: sum of 3 quarters · filed 2023-08-11 | $10.20M derived: sum of 4 quarters · filed 2023-08-11 | ||||||||||||
| 2022-03-31 | $7.00M 10-Q · filed 2023-05-12 | $6.84M derived: sum of 2 quarters · filed 2023-05-12 | $10.20M derived: sum of 3 quarters · filed 2023-05-12 | $56.53M derived: sum of 4 quarters · filed 2023-05-12 | ||||||||||||
| 2021-12-31 | -$160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.19M derived: sum of 2 quarters · filed 2023-03-31 | $49.53M derived: sum of 3 quarters · filed 2023-03-31 | $50.79M 10-K · filed 2023-03-31 | ||||||||||||
| 2021-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $49.69M derived: sum of 2 quarters · filed 2022-11-10 | $50.95M 10-Q · filed 2022-11-10 | $49.70M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||
| 2021-06-30 | $46.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $47.59M 10-Q · filed 2022-08-12 | $46.34M derived: sum of 3 quarters · filed 2022-08-12 | $45.09M derived: sum of 4 quarters · filed 2022-08-12 | ||||||||||||
| 2021-03-31 | $1.26M 10-Q · filed 2022-05-06 | $10.00K derived: sum of 2 quarters · filed 2022-05-06 | -$1.24M derived: sum of 3 quarters · filed 2022-05-06 | -$1.69M derived: sum of 4 quarters · filed 2022-05-06 | ||||||||||||
| 2020-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$2.50M derived: sum of 2 quarters · filed 2022-03-30 | -$2.96M derived: sum of 3 quarters · filed 2022-03-30 | -$3.44M 10-K · filed 2022-03-30 | ||||||||||||
| 2020-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$1.70M derived: sum of 2 quarters · filed 2021-11-08 | -$2.19M 10-Q · filed 2021-11-08 | -$1.67M derived: sum of 4 quarters · filed 2022-03-30 | ||||||||||||
| 2020-06-30 | -$456.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$939.00K 10-Q · filed 2021-08-16 | -$420.00K derived: sum of 3 quarters · filed 2022-03-30 | -$536.00K derived: sum of 4 quarters · filed 2022-03-30 | ||||||||||||
| 2020-03-31 | -$483.00K 10-Q · filed 2021-05-07 | $36.00K derived: sum of 2 quarters · filed 2022-03-30 | -$80.00K derived: sum of 3 quarters · filed 2022-03-30 | $32.22M derived: sum of 4 quarters · filed 2022-03-30 | ||||||||||||
| 2019-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $403.00K derived: sum of 2 quarters · filed 2022-03-30 | $32.70M derived: sum of 3 quarters · filed 2022-03-30 | $46.80M 10-K · filed 2022-03-30 | ||||||||||||
| 2019-09-30 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $32.18M derived: sum of 2 quarters · filed 2020-11-06 | $46.28M 10-Q · filed 2020-11-06 | $48.79M derived: sum of 4 quarters · filed 2021-03-12 | ||||||||||||
| 2019-06-30 | $32.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $46.40M 10-Q · filed 2020-08-07 | $48.91M derived: sum of 3 quarters · filed 2021-03-12 | $48.91M derived: sum of 4 quarters · filed 2021-03-12 | ||||||||||||
| 2019-03-31 | $14.10M 10-Q · filed 2020-05-08 | $5.18M 10-Q · filed 2019-05-09 | $16.61M derived: sum of 2 quarters · filed 2021-03-12 | $16.62M derived: sum of 3 quarters · filed 2021-03-12 | ||||||||||||
| 2018-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.52M derived: sum of 2 quarters · filed 2021-03-12 | $56.18M 10-K · filed 2021-03-12 | |||||||||||||
| 2018-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $53.68M 10-Q · filed 2019-11-06 | ||||||||||||||
| 2018-06-30 | $53.67M 10-Q · filed 2019-08-07 | |||||||||||||||
| 2017-12-31 | $16.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $18.28M derived: sum of 2 quarters · filed 2020-03-06 | $32.99M derived: sum of 3 quarters · filed 2020-03-06 | $37.95M 10-K · filed 2020-03-06 | ||||||||||||
| 2017-09-30 | $1.50M 10-Q · filed 2017-11-14 | $16.21M derived: sum of 2 quarters · filed 2018-08-10 | $21.17M 10-Q · filed 2018-11-08 | |||||||||||||
| 2017-06-30 | $14.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $17.17M 10-Q · filed 2018-08-10 | ||||||||||||||
| 2017-03-31 | $2.46M 10-Q · filed 2018-05-10 | |||||||||||||||
| 2016-12-31 | $9.74M 10-K · filed 2019-03-14 | |||||||||||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | |||||||||||||||
| 2015-12-31 | $3.88M 10-K · filed 2018-03-16 | |||||||||||||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 | $75.00K derived: sum of 2 quarters · filed 2014-11-14 | $1.87M derived: sum of 3 quarters · filed 2014-11-14 | $8.73M derived: sum of 4 quarters · filed 2014-11-14 | ||||||||||||
| 2014-06-30 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $1.87M derived: sum of 2 quarters · filed 2014-09-29 | $8.73M derived: sum of 3 quarters · filed 2014-09-29 | $8.73M 10-K · filed 2014-09-29 | ||||||||||||
| 2014-03-31 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | $8.65M derived: sum of 2 quarters · filed 2014-05-09 | $8.66M 10-Q · filed 2014-05-09 | $9.76M derived: sum of 4 quarters · filed 2014-11-14 | $58.12M 10-Q · filed 2014-05-09 | |||||||||||
| 2013-12-31 | $6.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $6.87M 10-Q · filed 2014-02-14 | $7.97M derived: sum of 3 quarters · filed 2014-11-14 | $10.80M derived: sum of 4 quarters · filed 2014-11-14 | $56.33M 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $290.00 10-Q · filed 2014-11-14 | $1.10M derived: sum of 2 quarters · filed 2014-11-14 | $3.94M derived: sum of 3 quarters · filed 2014-11-14 | $3.94M derived: sum of 4 quarters · filed 2014-11-14 | $49.47M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $3.94M derived: sum of 2 quarters · filed 2014-09-29 | $3.94M derived: sum of 3 quarters · filed 2014-09-29 | $4.03M 10-K · filed 2014-09-29 | $49.47M 10-K · filed 2013-09-11 | |||||||||||
| 2013-03-31 | $2.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | $2.84M derived: sum of 2 quarters · filed 2014-05-09 | $2.93M 10-Q · filed 2014-05-09 | $2.94M derived: sum of 4 quarters · filed 2014-09-29 | $48.36M 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $94.18K 10-Q · filed 2014-02-14 | $103.22K derived: sum of 3 quarters · filed 2014-09-29 | $2.85M derived: sum of 4 quarters · filed 2014-09-29 | $45.53M 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | $94.18K 10-Q · filed 2013-11-14 | $103.22K derived: sum of 2 quarters · filed 2014-09-29 | $2.85M derived: sum of 3 quarters · filed 2014-09-29 | $2.87M derived: sum of 4 quarters · filed 2014-09-29 | $45.53M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $9.04K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $2.75M derived: sum of 2 quarters · filed 2014-09-29 | $2.78M derived: sum of 3 quarters · filed 2014-09-29 | $3.23M 10-K · filed 2014-09-29 | $45.43M 10-K/A · filed 2012-10-26 | |||||||||||
| 2012-03-31 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $2.77M derived: sum of 2 quarters · filed 2013-05-15 | $3.22M 10-Q · filed 2013-05-15 | $3.24M derived: sum of 4 quarters · filed 2013-09-11 | $45.42M 10-Q · filed 2012-05-14 | |||||||||||
| 2011-12-31 | $22.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | $473.22K 10-Q · filed 2013-02-14 | $495.28K derived: sum of 3 quarters · filed 2013-09-11 | $1.99M derived: sum of 4 quarters · filed 2013-09-11 | $42.68M 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $451.10K 10-Q · filed 2012-11-14 | $473.16K derived: sum of 2 quarters · filed 2013-09-11 | $1.96M derived: sum of 3 quarters · filed 2013-09-11 | $42.66M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $22.07K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $1.51M derived: sum of 2 quarters · filed 2013-09-11 | $1.66M 10-K · filed 2013-09-11 | |||||||||||||
| 2011-03-31 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | $1.64M 10-Q · filed 2012-05-14 | ||||||||||||||
| 2010-12-31 | $149.28K 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-06-30 | $12.15M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |